TMO
Income statement / Annual
Last year (2023), Thermo Fisher Scientific Inc.'s total revenue was $42.86 B,
a decrease of 4.58% from the previous year.
In 2023, Thermo Fisher Scientific Inc.'s net income was $6.00 B.
See Thermo Fisher Scientific Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$42.86 B
|
$44.92 B
|
$39.21 B
|
$32.22 B
|
$25.54 B
|
$24.36 B
|
$20.92 B
|
$18.27 B
|
$16.97 B
|
$16.89 B
|
| Cost of Revenue |
$27.63 B |
$25.42 B |
$18.98 B |
$15.71 B |
$13.72 B |
$12.99 B |
$10.96 B |
$9.46 B |
$8.78 B |
$8.97 B |
| Gross Profit |
$15.22 B |
$19.50 B |
$20.23 B |
$16.51 B |
$11.83 B |
$11.36 B |
$9.96 B |
$8.82 B |
$8.18 B |
$7.92 B |
| Gross Profit Ratio |
0.36 |
0.43 |
0.52 |
0.51 |
0.46 |
0.47 |
0.48 |
0.48 |
0.48 |
0.47 |
| Research and Development
Expenses |
$1.34 B
|
$1.47 B
|
$1.41 B
|
$1.18 B
|
$1.00 B
|
$967.00 M
|
$888.00 M
|
$754.80 M
|
$692.30 M
|
$691.10 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$6.57 B
|
$7.13 B
|
$6.84 B
|
$5.76 B
|
$4.93 B
|
$4.82 B
|
$4.41 B
|
$4.04 B
|
$3.72 B
|
$3.99 B
|
| Other Expenses |
-$65.00 M |
$2.40 B |
$1.76 B |
$1.67 B |
$1.71 B |
$9.00 M |
-$28.00 M |
-$4.10 M |
-$15.50 M |
$16.40 M |
| Operating Expenses |
$7.91 B |
$10.99 B |
$10.01 B |
$8.61 B |
$7.65 B |
$7.53 B |
$6.89 B |
$6.18 B |
$5.73 B |
$6.01 B |
| Cost And Expenses |
$35.54 B |
$36.41 B |
$28.99 B |
$24.33 B |
$21.36 B |
$20.53 B |
$17.85 B |
$15.64 B |
$14.51 B |
$14.98 B |
| Interest Income |
$879.00 M |
$272.00 M |
$43.00 M |
$65.00 M |
$224.00 M |
$137.00 M |
$81.00 M |
$48.40 M |
$30.60 M |
$47.70 M |
| Interest Expense |
$1.38 B |
$726.00 M |
$536.00 M |
$553.00 M |
$676.00 M |
$667.00 M |
$592.00 M |
$469.60 M |
$414.90 M |
$479.90 M |
| Depreciation &
Amortization |
$3.41 B
|
$3.38 B
|
$2.59 B
|
$2.33 B
|
$2.28 B
|
$2.27 B
|
$2.03 B
|
$1.76 B
|
$1.69 B
|
$1.68 B
|
| EBITDA |
$10.72 B
|
$12.06 B
|
$12.17 B
|
$10.20 B
|
$6.61 B
|
$6.25 B
|
$5.15 B
|
$4.44 B
|
$4.15 B
|
$3.65 B
|
| EBITDA Ratio |
0.25 |
0.27 |
0.31 |
0.32 |
0.26 |
0.26 |
0.25 |
0.24 |
0.24 |
0.22 |
| Operating Income Ratio
|
0.17
|
0.19
|
0.26
|
0.24
|
0.18
|
0.16
|
0.14
|
0.13
|
0.14
|
0.15
|
| Total Other
Income/Expenses Net |
-$1.02 B
|
-$558.00 M
|
-$1.19 B
|
-$569.00 M
|
-$524.00 M
|
-$41.00 M
|
-$125.00 M
|
-$193.30 M
|
-$130.80 M
|
$614.60 M
|
| Income Before Tax |
$6.30 B |
$7.84 B |
$8.84 B |
$7.23 B |
$4.07 B |
$3.26 B |
$2.43 B |
$2.02 B |
$1.94 B |
$2.09 B |
| Income Before Tax Ratio
|
0.15
|
0.17
|
0.23
|
0.22
|
0.16
|
0.13
|
0.12
|
0.11
|
0.11
|
0.12
|
| Income Tax Expense |
$284.00 M |
$703.00 M |
$1.11 B |
$850.00 M |
$374.00 M |
$324.00 M |
$201.00 M |
-$1.40 M |
-$43.90 M |
$191.70 M |
| Net Income |
$6.00 B |
$6.95 B |
$7.73 B |
$6.38 B |
$3.70 B |
$2.94 B |
$2.23 B |
$2.02 B |
$1.98 B |
$1.89 B |
| Net Income Ratio |
0.14 |
0.15 |
0.2 |
0.2 |
0.14 |
0.12 |
0.11 |
0.11 |
0.12 |
0.11 |
| EPS |
15.53 |
17.73 |
19.61 |
16.1 |
9.24 |
7.31 |
5.64 |
5.12 |
4.96 |
4.76 |
| EPS Diluted |
15.45 |
17.64 |
19.46 |
15.98 |
9.17 |
7.24 |
5.59 |
5.09 |
4.92 |
4.71 |
| Weighted Average Shares
Out |
$386.00 M
|
$392.00 M
|
$394.00 M
|
$396.00 M
|
$400.00 M
|
$402.00 M
|
$395.00 M
|
$394.80 M
|
$398.70 M
|
$398.20 M
|
| Weighted Average Shares
Out Diluted |
$388.00 M
|
$394.00 M
|
$397.00 M
|
$399.00 M
|
$403.00 M
|
$406.00 M
|
$398.00 M
|
$397.40 M
|
$401.90 M
|
$402.30 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
